A study has found that a heart failure drug may relieve symptoms of postural orthostatic tachycardia syndrome (POTS). The drug, which has been identified as ivabradine in some reports, is being considered as a potential treatment for POTS. The exact details and outcomes of the study are not clear, but it appears to offer new hope for patients with the condition.